Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Telemed J E Health ; 2022 Mar 17.
Artigo em Inglês | MEDLINE | ID: mdl-35297666

RESUMO

Aim: To assess the overall satisfaction level of movement disorder specialists using a virtual platform during the COVID-19 pandemic. Methods: This was a multicenter cross-sectional survey for a 6-month period during the beginning of the COVID-19 pandemic. Movement disorder specialists, who utilized telehealth visits from March 2020 to August 2020, were included. The study surveys, including provider's satisfaction with the care that they were able to provide and visit quality, were completed by the provider after each visit. Results: A total of 206 visits, provided by movement disorder specialists, were analyzed. Zoom was the most popular platform used for remote visits (70, 34%). A backup platform was not needed in the majority of movement disorder visits (171, 83%). The majority of physicians were very satisfied or satisfied with the care provided (72.9%) and visit quality (61%). Conclusions: The satisfaction level of specialists using telemedicine during COVID-19 was high despite having encounters with elderly patients with cognitive impairment or lacking advanced skills with technology.

2.
Toxins (Basel) ; 12(11)2020 10 31.
Artigo em Inglês | MEDLINE | ID: mdl-33142833

RESUMO

Sialorrhea, or excessive saliva beyond the margin of the lip, is a common problem in many neurological diseases. Previously, sialorrhea has been underrecognized in Parkinson's disease (PD) patients. Despite this, many patients rank sialorrhea as one of the most debilitating complaints of Parkinson's disease. Previous treatment for sialorrhea has been suboptimal and has been plagued by significant side effects that are bothersome and can be dangerous in patients with a concurrent neurodegenerative disease. This review sought to review the anatomy, function, and etiology of sialorrhea in PD. It then sought to examine the evidence for the different treatments of sialorrhea in PD, and further examined newer evidence for safety and efficacy in minimally invasive treatment such as botulinum toxin.


Assuntos
Doença de Parkinson/complicações , Glândulas Salivares/fisiopatologia , Salivação , Sialorreia/etiologia , Inibidores da Liberação da Acetilcolina/uso terapêutico , Animais , Toxinas Botulínicas Tipo A/uso terapêutico , Humanos , Doença de Parkinson/diagnóstico , Doença de Parkinson/fisiopatologia , Glândulas Salivares/efeitos dos fármacos , Salivação/efeitos dos fármacos , Sialorreia/diagnóstico , Sialorreia/tratamento farmacológico , Sialorreia/fisiopatologia , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...